Frontiers in Oncology | Thoracic Oncology

Original Research

Published on 22 Sep 2023

Survival benefit with checkpoint inhibitors versus chemotherapy is modified by brain metastases in patients with recurrent small cell lung cancer

in Thoracic Oncology

Friederike C. Althoff
Lisa V. Schäfer
Fabian Acker
Lukas Aguinarte
Sophie Heinzen
Maximilian Rost
Akin Atmaca
Vivian Rosery
Jürgen Alt
Cornelius F. Waller

Frontiers in Oncology

doi 10.3389/fonc.2023.1273478

2,461 views

Editorial

Published on 21 Sep 2023

Editorial: Editor's challenge: Dr. Luciano Mutti - what is the true impact of ICIs on survival in the treatment of thoracic malignancies?

in Thoracic Oncology

Luciano Mutti
Steven G. Gray

Frontiers in Oncology

doi 10.3389/fonc.2023.1285031

998 views

Case Report

Published on 20 Sep 2023

Malignant lung PEComa (clear cell tumor): rare case report and literature review

in Thoracic Oncology

Marcos Adriano Garcia Campos
Lucas Fernandes Vasques
Rafael Goulart de Medeiros
Érico Murilo Monteiro Cutrim
Ana Júlia Favarin
Sarah Rebecca Machado Silva
Gyl Eanes Barros Silva
Marcelo Padovani de Toledo Moraes
Mariana Lopes Zanatta
Diego Aparecido Rios Queiróz

Frontiers in Oncology

doi 10.3389/fonc.2023.1260844

2,607 views
2 citations

Original Research

Published on 20 Sep 2023

The presence of autoantibodies is associated with improved overall survival in lung cancer patients

in Thoracic Oncology

Keying Jing
Huijuan Zhao
Jun Cai
Lianlian Chen
Peiming Zheng
Libo Ouyang
Gang Li
Rong Wang

Frontiers in Oncology

doi 10.3389/fonc.2023.1234847

2,070 views
2 citations

Original Research

Published on 18 Sep 2023

Nomogram combining clinical and radiological characteristics for predicting the malignant probability of solitary pulmonary nodules measuring ≤ 2 cm

in Thoracic Oncology

Mengchao Xue
Rongyang Li
Kun Wang
Wen Liu
Junjie Liu
Zhenyi Li
Zheng Ma
Huiying Zhang
Hui Tian
Yu Tian

Frontiers in Oncology

doi 10.3389/fonc.2023.1196778

1,741 views
3 citations

Original Research

Published on 18 Sep 2023

Real-world predictors of survival in patients with extensive-stage small-cell lung cancer in Manitoba, Canada: a retrospective cohort study

in Thoracic Oncology

David E. Dawe
Rebekah Rittberg
Iqra Syed
Mary Kate Shanahan
Daniel Moldaver
Oliver Bucher
Katie Galloway
Kayla Reynolds
James T. Paul
Craig Harlos

Frontiers in Oncology

doi 10.3389/fonc.2023.1191855

4,624 views
5 citations

Case Report

Published on 14 Sep 2023

Osimertinib inhibits brain metastases and improves long-term survival in a patient with advanced squamous cell lung cancer: a case report and literatures review

in Thoracic Oncology

Zhiqin Zhang
Jiamao Lin
Linke Yang
Yang Li

Frontiers in Oncology

doi 10.3389/fonc.2023.1188772

1,921 views
1 citation

Original Research

Published on 14 Sep 2023

Combined early palliative care for non-small-cell lung cancer patients: a randomized controlled trial in Chongqing, China

in Thoracic Oncology

Mengting Chen
Huiqing Yu
Liejun Yang
Hong Yang
Haoyang Cao
Lei Lei
Liling Ma
Shihong Liu
Ling Tian
Sixiong Wang

Frontiers in Oncology

doi 10.3389/fonc.2023.1184961

3,401 views
7 citations

Original Research

Published on 12 Sep 2023

Genomic profiling and sites of metastasis in non-small cell lung cancer

in Thoracic Oncology

Kok Hoe Chan
Arthi Sridhar
Ji Zheng Lin
Syed Hassan Raza Jafri

Frontiers in Oncology

doi 10.3389/fonc.2023.1212788

2,552 views
6 citations

Original Research

Published on 11 Sep 2023

Risk factor analysis for major mediastinal vessel invasion in thymic epithelial tumors based on multi-slice CT Imaging

in Thoracic Oncology

Yu-Hui Ma
Jie Zhang
Wei-Qiang Yan
Jiang-Tao Lan
Xiu-Long Feng
Shu-Mei Wang
Guang Yang
Yu-Chuan Hu
Guang-Bin Cui

Frontiers in Oncology

doi 10.3389/fonc.2023.1239419

1,367 views

Original Research

Published on 11 Sep 2023

Almonertinib plus chemotherapy versus almonertinib alone in second-line treatment of advanced non-small cell lung cancer with mutated epidermal growth factor receptor: a retrospective study

in Thoracic Oncology

Xiaoxu Fang
Yan Xiang
Kaihua Lu

Frontiers in Oncology

doi 10.3389/fonc.2023.1248690

1,744 views

Editorial

Published on 08 Sep 2023

Editorial: Optimizing outcomes and addressing adversities of immunotherapy in lung cancer

in Thoracic Oncology

Taiseer Al-Rajabi
Jarushka Naidoo
Jun Zhang

Frontiers in Oncology

doi 10.3389/fonc.2023.1277542

1,269 views

Original Research

Published on 06 Sep 2023

Right upper lobe segmentectomy and subsegmentectomy guided by classification pattern of peripheral segmental veins

in Thoracic Oncology

Zhikai Li
Shuangqing Chen
Dahu Ren
Yuhong Kong
Shun Xu
Guochen Duan
Xiaopeng Zhang

Frontiers in Oncology

doi 10.3389/fonc.2023.1179570

1,622 views
1 citation

Mini Review

Published on 06 Sep 2023

Combining stereotactic body radiotherapy with immunotherapy in stage IV non-small cell lung cancer

in Thoracic Oncology

Xiaoli Liu
Alexander Chi

Frontiers in Oncology

doi 10.3389/fonc.2023.1211815

6,446 views
7 citations

Clinical Trial

Published on 05 Sep 2023

Neoadjuvant chemoimmunotherapy cycle number selection for non-small cell lung cancer and clinical outcomes: a real-world analysis

in Thoracic Oncology

Baihua Zhang
Xiaotong Guo
Ran Jia
Zhan Wang
Jie Wu
Xiaoyan Chen
Jigang Li
Desong Yang
Xu Li
Wenxiang Wang

Frontiers in Oncology

doi 10.3389/fonc.2023.1200625

2,133 views
6 citations

Systematic Review

Published on 04 Sep 2023

Clinical outcomes of ramucirumab plus docetaxel in the treatment of patients with non-small cell lung cancer after immunotherapy: a systematic literature review

in Thoracic Oncology

Edward B. Garon
Carla Visseren-Grul
Maria Teresa Rizzo
Tarun Puri
Suresh Chenji
Martin Reck

Frontiers in Oncology

doi 10.3389/fonc.2023.1247879

6,949 views
10 citations